Thank you.
Mr. Elcock, back in December, you appeared before committee to discuss what you saw as the relatively minor procurement of Nuctech, but I want to focus on remarks that you made previously, when you said we should not be looking at one company when it comes to investments but at the Chinese government as a whole.
Before committee you discussed enhancement to security reviews, declaring that you might continue to want to buy from China if you've taken all of the security issues into review. Earlier this year, we issued revised guidelines on the national security review of investments to ensure that Canadian businesses must consider what national security review provisions mean for their business planning and supply chains, especially in the case of investments by state-owned or state-influenced investors.
What are the benefits to this approach and what else can be done?